Metastatic Melanoma

Showing NaN - NaN of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +12 more
  • Tucson, Arizona
  • +60 more
Jan 11, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Phoenix, Arizona
  • +48 more
Jan 3, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • Birmingham, Alabama
  • +848 more
Aug 24, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Melanoma Trial in Chicago (Photoimmunotherapy)

Terminated
  • Metastatic Melanoma
  • Photoimmunotherapy
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine, Department
Dec 1, 2021

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))

Completed
  • Metastatic Melanoma
  • MORAb-004 (monoclonal antibody)
  • Scottsdale, Arizona
  • +28 more
Aug 6, 2021

Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))

Terminated
  • Metastatic Melanoma
  • Head Neck Cancer
  • Birmingham, Alabama
  • +46 more
Jul 12, 2021

Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,

Completed
  • Metastatic Melanoma
  • +4 more
  • Bevacizumab
  • +4 more
  • San Francisco, California
  • +12 more
Jan 7, 2020

Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)

Completed
  • Advanced Melanoma
  • Metastatic Melanoma
  • Los Angeles, California
  • +13 more
Nov 14, 2019

Treatment Patterns and Clinical Response in Malignancy

Completed
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
    • Tucson, Arizona
    • +44 more
    Jun 11, 2019

    Metastatic Melanoma Trial in Chicago (Calcitriol, Temozolomide)

    Completed
    • Metastatic Melanoma
    • Chicago, Illinois
      Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
    May 23, 2019

    Metastatic Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in United States (Aldesleukin, Laboratory

    Completed
    • Metastatic Melanoma
    • +6 more
    • Aldesleukin
    • +2 more
    • Duarte, California
    • +20 more
    May 9, 2019

    Metastatic Melanoma Trial in United States (VCL-IM01 (encoding IL-2) with Electroporation)

    Completed
    • Metastatic Melanoma
    • VCL-IM01 (encoding IL-2) with Electroporation
    • Mobile, Alabama
    • +3 more
    Feb 25, 2019

    Metastatic Melanoma, Cutaneous Melanoma Trial in Chicago, Pittsburgh (HDI, KW2871)

    Completed
    • Metastatic Melanoma
    • Cutaneous Melanoma
    • Chicago, Illinois
    • +1 more
    Feb 19, 2018

    Metastatic Melanoma Trial in United States (Cisplatin, ALT-801)

    Completed
    • Metastatic Melanoma
    • Los Angeles, California
    • +7 more
    Oct 26, 2016

    Metastatic Melanoma Trial in Worldwide (Allovectin-7®, Dacarbazine (DTIC), Temozolomide (TMZ))

    Completed
    • Metastatic Melanoma
    • Allovectin-7®
    • +2 more
    • Tucson, Arizona
    • +87 more
    Sep 11, 2013

    Metastatic Melanoma Trial in Chicago (MAGE-3/Melan-A/gp100/NA PBMC, rhIL-12 (drug), MAGE-3/Melan-A/gp100/NA17 Peptide-pulsed

    Completed
    • Metastatic Melanoma
    • MAGE-3/Melan-A/gp100/NA PBMC, rhIL-12 (drug)
    • MAGE-3/Melan-A/gp100/NA17 Peptide-pulsed autologous PBMC, rhIL-12 with IL-2
    • Chicago, Illinois
      The University of Chicago
    Sep 4, 2013